IQVIA Holdings Inc.

IQVNYSEUSD
167.87 USD
2.81 (1.65%)🟢PRE MARKET (AS OF 05:13 AM EDT)
🟢Market: OPEN
Open?$170.11
High?$175.73
Low?$167.57
Prev. Close?$170.68
Volume?280
Avg. Volume?1.6M
VWAP?$171.46
Rel. Volume?0.00x
Bid / Ask
Bid?$160.43 × 100
Ask?$175.00 × 500
Spread?$14.57
Midpoint?$167.72
Valuation & Ratios
Market Cap?28.5B
Shares Out?166.9M
Float?160.5M
Float %?94.6%
P/E Ratio?20.57
P/B Ratio?4.58
EPS?$8.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Employees
93.0K
Market Cap
28.8B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed
2013-05-09
Address
2400 ELLIS ROAD
DURHAM, NC 27703
Phone: 919-998-2000
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.75Weak
Quick Ratio?0.75Weak
Cash Ratio?0.23Low
Debt/Equity?2.55High
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
20.6FAIR
P/B?
4.58FAIR
P/S?
1.71CHEAP
P/FCF?
13.5CHEAP
EV/EBITDA?
12.1FAIR
EV/Sales?
2.55CHEAP
Returns & Efficiency
ROE?
22.3%STRONG
ROA?
4.7%FAIR
Cash Flow & Enterprise
FCF?$2.1B
Enterprise Value?$42.4B
Fundamentals ratios updated end of day